methyl 4-amino-2-(2-aminoethyl)butanoate dihydrochloride, 95.0%, 250mg

3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 100g

5-Bromo-N-(diphenylmethylene)-2-pyrimidinamine, 95+%, 500mg

2-Bromo-2'-nitroacetophenone, 98.0%, 100g

Hafniumoxide, 98% +(Zr <1.5%), 100g

1-Bromo-2,3-difluorobenzene, 97.0%, 1g

2-(2'-Aminoethyl)-1-N-methylpyrrolidine, 98.0%, 10g

Dichloro(1,5-cyclooctadiene)platinum(II), 99.0%, 5g

NOTOGINSENOSIDE R1, 98%, 250mg

Methylionone (mixture of alpha- and beta-, predominantly alpha-n-isomer)>80.0%(GC)25mL

4-Bromo-2-hydrazinylbenzoic acid hydrochloride, 97.0%, 5g

4-(4-(Benzyloxy)benzyl)piperidine hydrochloride, 97%, 5g

McFarland PMS 0.5